Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting

CCO Oncology Podcast - Un podcast de Clinical Care Options

Catégories:

Listen to this expert overview of the most interesting findings related to the clinical use of bispecific antibody therapy for relapsed/refractory multiple myeloma that were presented at the 2024 annual American Society of Hematology meeting.

Visit the podcast's native language site